Clinical trials
Limbal Stem Cell Deficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 8 |
| Recruiting | 7 |
| Available | 2 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Terminated | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 4 |
| Chunxiao Wang | 2 |
| Claris Biotherapeutics, Inc. | 2 |
| Royan Institute | 2 |
| BRIM Biotechnology Inc. | 1 |
| CHU de Quebec-Universite Laval | 1 |
| CellSeed France S.A.R.L. | 1 |
| Chang Gung Memorial Hospital | 1 |
| He Eye Hospital | 1 |
| Hospices Civils de Lyon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Limbal Stem Cell Deficiency | 35 |
| Corneal Diseases | 5 |
| Aniridia | 4 |
| Corneal Injuries | 2 |
| Corneal Neovascularization | 2 |
| Keratitis | 2 |
| Pemphigoid, Benign Mucous Membrane | 2 |
| Stevens-Johnson Syndrome | 2 |
| Burns, Chemical | 1 |
| Cataract | 1 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.